Company news

Grace Therapeutics, Inc. news in 2026

Grace Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Grace Therapeutics Announces Participation in Upcoming Industry and Investor Events in November 2026

November 5, 2026

Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference

September 3, 2026

Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update

August 13, 2026

Grace Therapeutics Announces $10 Million Private Placement

August 4, 2026

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration

July 28, 2026

Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update

June 18, 2026

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104

April 23, 2026

Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026

April 14, 2026

Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences

March 19, 2026

Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

February 25, 2026

Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update

February 12, 2026

Decks in 2026